Pharmaceutical composition suitable for influencing the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 33/00 (2006.01) A61K 33/34 (2006.01)

Patent

CA 2074639

The pharmaceutical composition according to the invention comprises i) one or more, pharmaceutically acceptable, water- soluble compounds of boron, fluorine, magnesium, vanadium, manganese, iron, cobalt, nickel, copper, zinc and molybdenum, which compounds do not precipitate with each other or with the other components of the composition and exhibit a neutral or acidic pH in an aqueous medium; ii) glycine; iii) glycerol; iv) L-(+)-ascorbic acid; v) succinic acid; vi) a neutral or acidic and water-soluble, pharmaceutically acceptable salt of ethylenediamine tetraacetic acid; vii) potassium sodium tartrate; viii) L-(+)-tartaric acid. The composition can be used for the treatment of mucoviscidosis and chronic pain syndromes deriving from locomotor diseases or accompanying diseases of tumorous origin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical composition suitable for influencing the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition suitable for influencing the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition suitable for influencing the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1942465

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.